Alzheimer's disease

Where the future of Alzheimer's drugs is heading
Axios
Fri, 06/28/24 - 11:15 am
Alzheimer's disease
drug development
Eli Lilly
5 FDA Decisions to Watch in the Second Half of 2024
BioSpace
Mon, 06/24/24 - 11:29 am
FDA
Eli Lilly
donanemab
Alzheimer's disease
Adaptimmune
afami-cel
advanced synovial sarcoma
Lykos Therapeutics
MDMA
PTSD
Bristol Myers Squibb
KarXT
schizophrenia
Daiichi Sankyo
AstraZeneca
Dato-DXd
non-small cell lung cancer
What Would a Donanemab Approval Mean for Leqembi?
BioSpace
Mon, 06/24/24 - 10:47 am
Eli Lilly
donanemab
Biogen
Eisai
Leqembi
FDA
Alzheimer's disease
How Roche is finding better ways to diagnose brain conditions like Alzheimer’s and Parkinson’s disease
Pharma Voice
Tue, 06/18/24 - 11:34 am
Roche
biomarkers
Alzheimer's disease
Parkinson's Disease
R&D
Eli Lilly Scores Another Major Win and Lines Up Its Next Blockbuster
Motley Fool
Sun, 06/16/24 - 08:54 pm
Eli Lilly
Alzheimer's disease
donanemab
Lilly’s adcomm win shows amyloid and tau will likely dominate Alzheimer’s — for now
Pharma Voice
Thu, 06/13/24 - 10:50 am
Eli Lilly
Alzheimer's disease
donanemab
amyloid
tau
Alzheimer’s Drug Developer Alzheon Closes $100M Series E Financing
Genetic Engineering News
Wed, 06/12/24 - 11:29 pm
Alzheon
clinical trials
funding
Alzheimer's disease
valiltramiprosate
Lilly Alzheimer’s drug gets unanimous backing of FDA panel
BioPharma Dive
Mon, 06/10/24 - 06:09 pm
Eli Lilly
FDA
donanemab
Alzheimer's disease
FDA accepts Eisai's subcutaneous Leqembi filing, sets January 25 decision date
Fierce Pharma
Mon, 06/10/24 - 11:19 am
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
FDA staff raise no major concerns about Eli Lilly Alzheimer's drug
Reuters
Thu, 06/6/24 - 09:11 pm
Eli Lilly
FDA
Alzheimer's disease
donanemab
FDA lays out donanemab concerns ahead of meeting, as Lilly vigorously defends safety
Fierce Biotech
Thu, 06/6/24 - 11:45 am
Eli Lilly
donanemab
FDA
Alzheimer's disease
Lucy Therapeutics secures $12.5m for neurological treatment development
Pharmaceutical Business Review
Wed, 05/29/24 - 11:49 am
Lucy Therapeutics
funding
Alzheimer's disease
Parkinson's Disease
Otsuka Drops Alzheimer’s Agitation Drug Following Phase III Failure
BioSpace
Wed, 05/22/24 - 11:20 am
Otsuka
Alzheimer's disease
Alzheimer's agitation
clinical trials
AVP-786
Voyager doses first patient with anti-tau antibody in Alzheimer’s trial
Clinical Trials Arena
Mon, 05/20/24 - 11:05 am
Voyager Therapeutics
Alzheimer's disease
clinical trials
VY-TAU01
Eisai starts rolling submission for injectable version of Alzheimer's drug with US FDA
Reuters
Tue, 05/14/24 - 11:03 pm
Eisai
Biogen
Leqembi
FDA
Alzheimer's disease
Takeda wagers up to $2.2bn on AC Immune Alzheimer’s shot
Pharmaphorum
Mon, 05/13/24 - 11:13 am
Takeda
AC Immune
Alzheimer's disease
ACI-24.060
Acumen doses first patient in Phase II Alzheimer’s disease trial
Clinical Trials Arena
Thu, 05/9/24 - 07:16 pm
Acumen Pharmaceuticals
clinical trials
sabirnetug
Alzheimer's disease
Lilly gets a date with FDA to discuss Alzheimer's med donanemab
Fierce Biotech
Tue, 05/7/24 - 11:21 am
Eli Lilly
FDA
advisory committees
Alzheimer's disease
donanemab
Eli Lilly Gears Up for Donanemab Adcomm as FDA Ponders Changes to Format
BioSpace
Mon, 05/6/24 - 11:43 am
Eli Lilly
FDA
donanemab
advisory committees
Alzheimer's disease
Alzheimer's drug adoption in US slowed by doctors' skepticism
Reuters
Tue, 04/23/24 - 09:47 pm
Eisai
Biogen
Leqembi
physicians
Alzheimer's disease

Pages